PLEASANTON, Calif.— The Cooper Companies, Inc. (NYSE:COO) reported financial results for the fiscal fourth quarter and full year ended Oct. 31, 2014. The report reflected the company’s recent $1.1 billion acquisition of Sauflon Pharmaceuticals, a European manufacturer and distributor of soft contact lenses and solutions, which took place in August.

Overall, Cooper Companies’ revenue for the full year rose 8 percent to $1,717.8 million. CooperVision (CVI) revenues reached $1,392.6 million, up 10 percent from fiscal 2013, up 10 pro forma, while Cooper Surgical’s revenue was $325.1 million for year, up 2 percent from fiscal 2013, 2 percent in constant currency.

The company’s total fourth quarter revenue increased 14 percent year-over-year to $468.0 million. CooperVision’s revenue for the three-month fourth quarter was up 18 percent to reach $385.4 million.

Commenting on the results, Robert S. Weiss, Cooper's president and chief executive officer said, "I am pleased to report record revenue this year at both our business units and record non-GAAP earnings per share. We accomplished this through continued market share gains across all geographies and the acquisition of Sauflon Pharmaceuticals. Our business fundamentals remain strong and we expect fiscal 2015 to be a year of strong operational performance."